Evidence map›Paper›PMID 41961445›Full record

ArticleCerebellum (London, England)2026

Analysis of Presurgical Language in Children with Posterior Fossa Tumours Relative to Postoperative Speech Outcomes: Findings from the European CMS Study.

Aliene Reinders, Cheyenne Svaldi, Annet Kingma, Jonathan Kjær Grønbæk, Ditte Boeg Thomsen, Karin Persson, René Mathiasen, Christine Dahl, Andrea Carai, Bianca Andreozzi and 8 more

Abstract read
In one paragraph

Article in Cerebellum (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Aliene ReindersCenter for Language and Cognition Groningen (CLCG), University of Groningen, Groningen, The Netherlands.
Cheyenne SvaldiCenter for Language and Cognition Groningen (CLCG), University of Groningen, Groningen, The Netherlands.
Annet KingmaDepartment of Pediatrics/Pediatric Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Jonathan Kjær GrønbækDepartment of Paediatric and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Ditte Boeg ThomsenDepartment of Nordic Studies and Linguistics, University of Copenhagen, Copenhagen, Denmark.
Karin PerssonDepartment of Health Sciences, Lund University, Lund, Sweden.
René MathiasenDepartment of Paediatric and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Christine DahlDepartment of Paediatric and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Andrea CaraiNeurosurgery Unit, Bambino Gesù Children's Hospital, Rome, Italy.
Bianca AndreozziDepartment of Hematology/oncology, Cell Therapy, Gene Therapies and Hematopoietic Transplant, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Angela MastronuzziDepartment of Hematology/oncology, Cell Therapy, Gene Therapies and Hematopoietic Transplant, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Barry PizerUniversity of Liverpool, Liverpool, UK.
Colin ThorbinsonDepartment of Oncology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Kristian AquilinaDepartment of Neurosurgery, Great Ormond Street Hospital, London, UK.
Eelco HovingOncological Pediatric Neurosurgery, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Marianne JuhlerDepartment of Neurosurgery, Aarhus University Hospital, Aarhus, Denmark.
Roel JonkersCenter for Language and Cognition Groningen (CLCG), University of Groningen, Groningen, The Netherlands.
Vânia de AguiarCenter for Language and Cognition Groningen (CLCG), University of Groningen, Groningen, The Netherlands. vania.de.aguiar@rug.nl.

Funding

Inge Lehmann grant 10.46540/4302-00027BNederlandse Organisatie voor Wetenschappelijk Onderzoek VI.Vidi.201.003
6 · The paper itself

Abstract

Posterior Fossa Syndrome is a common complication in children following posterior fossa tumour surgery, typically marked by transient postoperative speech impairment (POSI; i.e., mutism or reduced speech). Previous studies suggest that children who develop POSI show different language profiles postoperatively compared to those who do not. It remains unclear to what extent these language difficulties exist preoperatively and whether preoperative language difficulties are related to postoperative speech status. This study provides the first comprehensive analysis of preoperative language samples, using data from the European study of Cerebellar Mutism Syndrome. Patients with and without POSI were compared to identify preoperative language characteristics that may be associated with POSI. Preoperative language samples of 34 patients aged 3–16 years were analysed (16 developed POSI; 18 did not). We compared global sample characteristics and language performance across four levels: the semantic, lexical, morphosyntactic, and phonological level. No significant preoperative language differences were found between the groups for the four levels of language processing (all p-values > 0.137). Children who developed POSI produced more unintelligible speech preoperatively (β = -14.455, p = .024), with better intelligibility related to older age (age×group: β = 0.152, p = .007), only for the group with POSI. While the main focus of this study was on language, these findings suggest that risk factors for POSI within the domain of verbal output may lie more in preoperative speech. A comprehensive analysis of preoperative speech may provide valuable insight into speech characteristics potentially related to POSI.

Indexed as

Infratentorial NeoplasmsLanguagePostoperative ComplicationsSpeechSpeech DisordersAdolescentChildChild, PreschoolEuropeFemaleHumansMaleMutismTreatment OutcomeCerebellar mutism syndromeInfratentorial neoplasmsLanguage disordersMutismPosterior fossa syndromePreoperative language impairment

Identifiers

PMID41961445
PMCPMC13068704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.